Pharmaceutical Executive April 1, 2025
Mike Hollan

LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.

LillyDirect will now offer Alzheimer’s care.

Eli Lilly announced the addition to its digital healthcare platform, which will be able to provide both in-person and telehealth services. According to Lilly, the majority of people in the US living with Alzheimer’s have not been formally diagnosed, yet they still require access to care and services. The problems with getting formally diagnosed are expected to get worse in the coming year.

In a press release, Eli Lilly’s chief medical officer David Hyman, MD, said, “We know that early diagnosis and care can make a big difference for people living with Alzheimer’s disease. By...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
GLP-1 drug use for weight loss has soared, costing billions
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers

Share This Article